Eli Lilly has shared positive results from a Phase II clinical trial (NCT06230523) evaluating eloralintide, an investigational once-weekly, selective amylin receptor, in adults with obesity or ...
Children’s National Hospital is poised to recruit patients for a new clinical trial that will take on an old, implacable foe: children’s solid tumors. Little progress has been made in 30 years.
Roughly 70 to 80% of ovarian cancer cases are diagnosed at an advanced stage,1 where treatment options are limited and ...
Clinical trial sites often open and close rapidly, with 60% ceasing operations within the first year, impacting patient ...
Stocktwits on MSN
Psyence BioMed Doses Multiple Patients and Expands Clinical Sites in Phase IIb Study for Adjustment Disorder in Palliative Care
Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today ...
Data gathered up to day 57 after the second dose indicated that VLA1601 was generally well tolerated and safe across all ...
Avisi Technologies has released positive 12-month clinical data on the VisiPlate Aqueous Shunt from the VITA Trial. The VITA ...
Cecilia Bahit, MD, and Carolyn Lam, MBBS, PhD, FACC, discuss the barriers patients face when seeking access to clinical trial ...
Examining how shifting leadership patterns in breast cancer research signal growing international participation—and the ...
If it weren’t for post hoc analyses and findings from curious academic labs, the substantial list of biological differences that separates the sexes would still be relegated to the shadows. That list ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback